Kevin Barber

Kevin Barber has extensive experience in regulatory affairs and strategy across multiple organizations in the pharmaceutical industry. Currently serving as Senior Vice President of Global Regulatory Strategy and Submissions at Everest Clinical Research, Kevin previously held the position of Senior Vice President of Regulatory Consulting at Syner-G BioPharma Group. Notably, Kevin spent several years at Rho as both Senior Vice President and Vice President of Regulatory Strategy and Submissions. Additional roles include Vice President of Regulatory Affairs at Novan Therapeutics and various leadership positions at Actavis, Cato Research, and academic appointments at Duke University. Kevin holds a Ph.D. in Biomedical Engineering from Duke University and a Master's degree in Aerospace Engineering from Virginia Tech.